CLOSE X
GO

UTI Healthcare Fund-Reg(G)

very highequitypharma & health care
280.61 -0.32(-0.11%) NAV as on 14 Jan 2026
-2.31 % 1 M
0.06 % 1 Y
23.57 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.27

As on 31 Dec, 2025
age-icon Age :

20 yrs 5 m

Since 01 08 ,2005
exit_load Exit Load :

1%

aum AUM :

1,101.63 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Mid Growth

Portfolio_book_value Portfolio Price To Book Value :

7.03

Min_Investment Min. Investment :

SIP 500 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Kamal Gada

LATEST ASSET & PORTFOLIO ALLOCATION

as on Dec 31 ,2025
Others 0.60 %
Equity 99.40 %

TOP HOLDINGS

Sun Pharmaceutical Industries...9.37 %
Ajanta Pharma Ltd.7.16 %
Lupin Ltd.5.65 %
Glenmark Pharmaceuticals Ltd.4.06 %
Gland Pharma Ltd.3.60 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs75.58
Hospital & Healthcare Services22.38
Business Support1.06
Medical Equipment/Supplies/Accessories0.37
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 14-Jan-2026)157.00143.40223.40268.23280.61
Net Assets(Rs Crores) (as on 14-Jan-2026) 776.23 654.50 947.26 1042.04 1101.63
Scheme Returns(%)(Absolute)12.06-8.8155.5418.696.11
B'mark Returns(%)(Absolute)NANANANANA
Category Rank50/7568/7621/905/10282/113

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

UTI Healthcare Fund-Reg(G)Very HighEquity280.61-0.32(-0.11%)NAV As on 14 Jan, 202601-Aug-2005Inception Date1,101.63AUM In Cr.0.06%1Y23.57%3Y13.98%5Y17.69%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.95-0.10(-0.34%)NAV As on 14 Jan, 202628-Dec-2015Inception Date1,310.50AUM In Cr.-0.83%1Y21.55%3Y14.19%5Y11.53%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors